179 related articles for article (PubMed ID: 14982812)
41. CNS-aspergillosis: are there new treatment options?
Schwartz S; Thiel E
Mycoses; 2003; 46 Suppl 2():8-14. PubMed ID: 15055138
[TBL] [Abstract][Full Text] [Related]
42. [Aspergillus bronchitis and aspergilloma treated successfully with voriconazole].
Freymond N; Le Loch JB; Devouassoux G; Harf R; Rakotomalala A; Pacheco Y
Rev Mal Respir; 2005 Nov; 22(5 Pt 1):811-4. PubMed ID: 16272984
[TBL] [Abstract][Full Text] [Related]
43. Steady-state pharmacokinetics of oral voriconazole and its primary metabolite, N-oxide voriconazole, pre- and post-autologous peripheral stem cell transplantation.
Amsden JR; Gubbins PO; McConnell S; Anaissie E
Antimicrob Agents Chemother; 2013 Jul; 57(7):3420-3. PubMed ID: 23629717
[TBL] [Abstract][Full Text] [Related]
44. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
Singh N; Limaye AP; Forrest G; Safdar N; Muñoz P; Pursell K; Houston S; Rosso F; Montoya JG; Patton P; Del Busto R; Aguado JM; Fisher RA; Klintmalm GB; Miller R; Wagener MM; Lewis RE; Kontoyiannis DP; Husain S
Transplantation; 2006 Feb; 81(3):320-6. PubMed ID: 16477215
[TBL] [Abstract][Full Text] [Related]
45. Aspergillus fumigatus tricuspid native valve endocarditis in a non-intravenous drug user.
Vassiloyanakopoulos A; Falagas ME; Allamani M; Michalopoulos A
J Med Microbiol; 2006 May; 55(Pt 5):635-638. PubMed ID: 16585653
[TBL] [Abstract][Full Text] [Related]
46. Treatment of refractory cerebral aspergillosis in a liver transplant recipient with voriconazole: case report and review of the literature.
Cherian T; Giakoustidis A; Yokoyama S; Heneghan M; O'Grady J; Rela M; Wendon J; Heaton DN; Verma A
Exp Clin Transplant; 2012 Oct; 10(5):482-6. PubMed ID: 23031086
[TBL] [Abstract][Full Text] [Related]
47. Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases.
Mathis AS; Shah NK; Friedman GS
Transplant Proc; 2004 Nov; 36(9):2708-9. PubMed ID: 15621130
[TBL] [Abstract][Full Text] [Related]
48. The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside.
Seyedmousavi S; Mouton JW; Melchers WJ; Brüggemann RJ; Verweij PE
Drug Resist Updat; 2014 Jul; 17(3):37-50. PubMed ID: 25066814
[TBL] [Abstract][Full Text] [Related]
49. Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema.
Purcell IF; Corris PA
Thorax; 1995 Dec; 50(12):1321-3. PubMed ID: 8553311
[TBL] [Abstract][Full Text] [Related]
50. Designing a treatment protocol with voriconazole to eliminate Aspergillus fumigatus from experimentally inoculated pigeons.
Beernaert LA; Pasmans F; Baert K; Van Waeyenberghe L; Chiers K; Haesebrouck F; Martel A
Vet Microbiol; 2009 Nov; 139(3-4):393-7. PubMed ID: 19574001
[TBL] [Abstract][Full Text] [Related]
51. [Anti-infectious activity of intravitreal injectable voriconazole microspheres on experimental rabbit fungal endophthalmitis of Aspergillus fumigatus].
Yang LN; Xin M; Wu XG; Jiang HR
Yao Xue Xue Bao; 2010 Jun; 45(6):778-84. PubMed ID: 20939190
[TBL] [Abstract][Full Text] [Related]
52. Better hospital nutrition needed to prevent and treat Aspergillus infections.
Curtis LT
Med Mycol; 2013 Apr; 51(3):336. PubMed ID: 22957477
[No Abstract] [Full Text] [Related]
53. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism.
Snelders E; van der Lee HA; Kuijpers J; Rijs AJ; Varga J; Samson RA; Mellado E; Donders AR; Melchers WJ; Verweij PE
PLoS Med; 2008 Nov; 5(11):e219. PubMed ID: 18998768
[TBL] [Abstract][Full Text] [Related]
54. Voriconazole for the treatment of disseminated nodular cutaneous aspergillosis in a patient affected by acute myeloid leukemia.
La Nasa G; Littera R; Maccioni A; Ledda A; Vacca A; Contu L
Hematol J; 2004; 5(2):178-80. PubMed ID: 15048069
[TBL] [Abstract][Full Text] [Related]
55. Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.
Donnelly JP; De Pauw BE
Clin Microbiol Infect; 2004 Mar; 10 Suppl 1():107-17. PubMed ID: 14748807
[TBL] [Abstract][Full Text] [Related]
56. Successful treatment of invasive pulmonary aspergillosis in a neonatal foal.
Hilton H; Galuppo L; Puchalski SM; Johnson L; Robinson K; Mohr FC; Maher O; Pusterla N
J Vet Intern Med; 2009; 23(2):375-8. PubMed ID: 19210313
[No Abstract] [Full Text] [Related]
57. Voriconazole: review of a broad spectrum triazole antifungal agent.
Kofla G; Ruhnke M
Expert Opin Pharmacother; 2005 Jun; 6(7):1215-29. PubMed ID: 15957974
[TBL] [Abstract][Full Text] [Related]
58. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
59. Successful treatment of invasive Aspergillus sinusitis with caspofungin and voriconazole.
Chirch L; Roche P; Fuhrer J
Ear Nose Throat J; 2008 Jan; 87(1):30-3. PubMed ID: 18357943
[TBL] [Abstract][Full Text] [Related]
60. Voriconazole in clinical practice.
Mikulska M; Novelli A; Aversa F; Cesaro S; de Rosa FG; Girmenia C; Micozzi A; Sanguinetti M; Viscoli C
J Chemother; 2012 Dec; 24(6):311-27. PubMed ID: 23174096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
